47 related articles for article (PubMed ID: 38689824)
1. Impact of reactive changes on multigene testing: histopathologic analysis of low-grade breast cancers with high-risk 21-gene recurrence scores.
Grabenstetter A; Brogi E; Thompson DM; Blinder VS; Norton L; Morrow M; Robson ME; Wen HY
Breast Cancer Res Treat; 2024 Jan; 203(1):153-161. PubMed ID: 37768520
[TBL] [Abstract][Full Text] [Related]
2. The REMAR (Rhein-Main-Registry) real-world study: prospective evaluation of the 21-gene breast recurrence score® assay in addition to Ki-67 for adjuvant treatment decisions in early-stage breast cancer.
Jackisch C; Anastasiadou L; Aulmann S; Argyriadis A; Möbus V; Solbach C; Baier P; Giesecke D; Ackermann S; Schulmeyer E; Gabriel B; Mosch D; Buchen S; Krapfl E; Hurst U; Vescia M; Tesch H; Thill M
Breast Cancer Res Treat; 2024 Jun; ():. PubMed ID: 38874685
[TBL] [Abstract][Full Text] [Related]
3. Nottingham prognostic x (NPx): a risk stratification tool in ER-positive HER2-negative breast cancer: a validation study.
Lashen AG; Toss M; Miligy I; Rewcastle E; Kiraz U; Janssen EAM; Green AR; Quinn C; Ellis I; Rakha EA
Histopathology; 2024 Jun; ():. PubMed ID: 38867570
[TBL] [Abstract][Full Text] [Related]
4. Clinical and molecular predictors of very late recurrence in oestrogen receptor-positive breast cancer patients.
Richman J; Schuster G; Buus R; Lopez-Knowles E; Dowsett M
Breast Cancer Res Treat; 2024 Jul; 206(1):195-205. PubMed ID: 38709373
[TBL] [Abstract][Full Text] [Related]
5. Association between pathological characteristics and recurrence score by OncotypeDX in resected T1-3 and N0-1 breast cancer: a real-life experience of a North Hungarian regional center.
Deme D; Tamaskovics BF; Jammoul N; Kovács S; Kayode EO; Grice JW; Telekes A
Pathol Oncol Res; 2024; 30():1611735. PubMed ID: 38689824
[No Abstract] [Full Text] [Related]
6. Are we Overtreating Hormone Receptor Positive Breast Cancer with Neoadjuvant Chemotherapy? Role of OncotypeDx
Kantor O; Barrera E; Kopkash K; Pesce C; Barrera E; Winchester DJ; Yao K
Ann Surg Oncol; 2019 Oct; 26(10):3232-3239. PubMed ID: 31342379
[TBL] [Abstract][Full Text] [Related]
7. Relationship of Oncotype Dx score with tumor grade, size, nodal status, proliferative marker Ki67 and Nottingham Prognostic Index in early breast cancer tumors in Saudi Population.
Durrani S; Al-Mushawa F; Heena H; Wani T; Al-Qahtani A
Ann Diagn Pathol; 2021 Apr; 51():151674. PubMed ID: 33360027
[TBL] [Abstract][Full Text] [Related]
8. Distribution patterns of 21-gene recurrence score in 980 Chinese estrogen receptor-positive, HER2-negative early breast cancer patients.
Wu J; Fang Y; Lin L; Fei X; Gao W; Zhu S; Zong Y; Chen X; Huang O; He J; Zhu L; Chen W; Li Y; Shen K
Oncotarget; 2017 Jun; 8(24):38706-38716. PubMed ID: 28404972
[TBL] [Abstract][Full Text] [Related]
9. The value of progesterone receptor expression in predicting the Recurrence Score for hormone-receptor positive invasive breast cancer patients.
Onoda T; Yamauchi H; Yagata H; Tsugawa K; Hayashi N; Yoshida A; Suzuki K; Sakurai O; Nakamura S
Breast Cancer; 2015 Jul; 22(4):406-12. PubMed ID: 24081457
[TBL] [Abstract][Full Text] [Related]
10. Impact of 21-Gene Breast Cancer Assay on Treatment Decision for Patients with T1-T3, N0-N1, Estrogen Receptor-Positive/Human Epidermal Growth Receptor 2-Negative Breast Cancer: Final Results of the Prospective Multicenter ROXANE Study.
Dieci MV; Guarneri V; Zustovich F; Mion M; Morandi P; Bria E; Merlini L; Bullian P; Oliani C; Gori S; Giarratano T; Orvieto E; Griguolo G; Michieletto S; Saibene T; Del Bianco P; De Salvo GL; Conte P;
Oncologist; 2019 Nov; 24(11):1424-1431. PubMed ID: 31152079
[TBL] [Abstract][Full Text] [Related]
11. OncotypeDX Testing Does Not Benefit Patients with Estrogen and Progesterone Receptor Positive Grade 1 Breast Cancers: A TAILORx Validated Study.
Sibia US; Mylander C; Martin T; Rosman M; Sanders TJ; Lee Y; Tafra L; Jackson RS
Hematol Oncol Stem Cell Ther; 2023 May; 16(4):412-419. PubMed ID: 37363979
[TBL] [Abstract][Full Text] [Related]
12. Perineural Invasion Predicts Unfavorable Prognosis in Patients With Invasive Breast Cancer.
Hosoya K; Wakahara M; Ikeda K; Umekita Y
Cancer Diagn Progn; 2023; 3(2):208-214. PubMed ID: 36875309
[TBL] [Abstract][Full Text] [Related]
13. Why the study of comparative psychology is important to neuroscientists.
Abramson CI
Front Behav Neurosci; 2022; 16():1095033. PubMed ID: 36703719
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
